Filing Details
- Accession Number:
- 0001209191-22-057333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-16 17:06:34
- Reporting Period:
- 2022-11-16
- Accepted Time:
- 2022-11-16 17:06:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Phio Pharmaceuticals Corp. | PHIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304395 | J Robert Bitterman | C/O Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough MA 01752 | Interim Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series D Preferred Stock, $0.0001 Par Value | Acquisiton | 2022-11-16 | 1 | $1,750.00 | 1 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The outstanding share of Series D Preferred Stock shall be redeemed in whole, but not in part, at any time: (i) if such redemption is approved by the Board of Directors in its sole discretion or (ii) automatically and effective upon the approval of an amendment to the Certificate of Incorporation to implement a reverse stock split. Upon redemption, the share of Series D Preferred Stock will receive consideration of $1,750.00 in cash.
Billionaire Hedge Funds
